Jean-Luc C Mougeot1, James M Davis2, Jing Zhao3, Kathleen A Sullivan2, Martin H Thornhill4, Patrick E McKnight5, Casey Stephens3, Peter B Lockhart2. 1. Department of Oral Medicine, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA. Electronic address: jean-luc.mougeot@atriumhealth.org. 2. Department of Oral Medicine, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA. 3. Center for Outcomes Research and Evaluation (Core), Carolinas Medical Center - Atrium Health, Charlotte, NC, USA. 4. Department of Oral Medicine, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA; Department of Oral and Maxillofacial Medicine, Surgery and Pathology, University of Sheffield School of Clinical Dentistry, Western Bank, Sheffield, UK. 5. Department of Psychology, George Mason University, Fairfax, VA, USA.
Abstract
BACKGROUND: Dentists are high prescribers of antibiotics for both treatment and prevention of infection, although there are few guidelines to aid clinicians. Given the worldwide concerns about unnecessary use of antibiotics, there is a need for a better understanding of dentists' use of these drugs for antibiotic prophylaxis (AP) to prevent distant site infections (i.e., infective endocarditis and prosthetic joint infection). OBJECTIVE: The aim of this study was to develop and implement an effective, self-reporting, cross-sectional, survey instrument that optimized the response rate and maximized reliability and validity for determining the beliefs and behaviors of a large and nationally representative group of generalist and specialist dentists concerning their use of AP. STUDY DESIGN: A 15-question survey (58 items) was developed in a structured process by a multidisciplinary team and configured for automated online dissemination to 3584 national Dental Practice-Based Research Network (DPBRN; hitherto referred to as "Network") practitioners. The implementation phase consisted of 3 waves of greater than 1000 Network members. Additionally, 47 randomly selected dentists were surveyed twice to assess test-retest reliability. RESULTS: Of 3584 eligible Network members, 2169 (60.5%) completed the survey. The age and geographic distributions of responders was similar to those of dentists in the 2019 American Dental Association census. Furthermore, test-retest weighted kappa values for the survey were acceptable (median 0.56; interquartile range 0.42-0.64). CONCLUSIONS: We developed a highly structured survey with a high response rate and good reliability that will allow us to obtain unique data on dentists' beliefs and practices regarding AP prescribing.
BACKGROUND: Dentists are high prescribers of antibiotics for both treatment and prevention of infection, although there are few guidelines to aid clinicians. Given the worldwide concerns about unnecessary use of antibiotics, there is a need for a better understanding of dentists' use of these drugs for antibiotic prophylaxis (AP) to prevent distant site infections (i.e., infective endocarditis and prosthetic joint infection). OBJECTIVE: The aim of this study was to develop and implement an effective, self-reporting, cross-sectional, survey instrument that optimized the response rate and maximized reliability and validity for determining the beliefs and behaviors of a large and nationally representative group of generalist and specialist dentists concerning their use of AP. STUDY DESIGN: A 15-question survey (58 items) was developed in a structured process by a multidisciplinary team and configured for automated online dissemination to 3584 national Dental Practice-Based Research Network (DPBRN; hitherto referred to as "Network") practitioners. The implementation phase consisted of 3 waves of greater than 1000 Network members. Additionally, 47 randomly selected dentists were surveyed twice to assess test-retest reliability. RESULTS: Of 3584 eligible Network members, 2169 (60.5%) completed the survey. The age and geographic distributions of responders was similar to those of dentists in the 2019 American Dental Association census. Furthermore, test-retest weighted kappa values for the survey were acceptable (median 0.56; interquartile range 0.42-0.64). CONCLUSIONS: We developed a highly structured survey with a high response rate and good reliability that will allow us to obtain unique data on dentists' beliefs and practices regarding AP prescribing.
Authors: Thomas J Cahill; James L Harrison; Paul Jewell; Igho Onakpoya; John B Chambers; Mark Dayer; Peter Lockhart; Nia Roberts; David Shanson; Martin Thornhill; Carl J Heneghan; Bernard D Prendergast Journal: Heart Date: 2017-02-17 Impact factor: 5.994
Authors: Martin H Thornhill; Mark J Dayer; Bernard Prendergast; Larry M Baddour; Simon Jones; Peter B Lockhart Journal: J Antimicrob Chemother Date: 2015-04-29 Impact factor: 5.790
Authors: Ellen Funkhouser; Kavya Vellala; Camille Baltuck; Rita Cacciato; Emily Durand; Deborah McEdward; Ellen Sowell; Sarah E Theisen; Gregg H Gilbert Journal: Eval Health Prof Date: 2016-01-10 Impact factor: 2.651
Authors: Peter B Lockhart; Joe Blizzard; Andréa L Maslow; Michael T Brennan; Howell Sasser; John Carew Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2012-12-20
Authors: Michael J Durkin; Kevin Hsueh; Ya Haddy Sallah; Qianxi Feng; S Reza Jafarzadeh; Kiraat D Munshi; Peter B Lockhart; Martin H Thornhill; Rochelle R Henderson; Victoria J Fraser Journal: J Am Dent Assoc Date: 2017-09-20 Impact factor: 3.634
Authors: Michael J Durkin; Qianxi Feng; Kyle Warren; Peter B Lockhart; Martin H Thornhill; Kiraat D Munshi; Rochelle R Henderson; Kevin Hsueh; Victoria J Fraser Journal: J Am Dent Assoc Date: 2018-05 Impact factor: 3.454
Authors: Peter B Lockhart; Martin H Thornhill; Jing Zhao; Larry M Baddour; Gregg H Gilbert; Patrick E McKnight; Casey Stephens; Jean-Luc Mougeot Journal: J Am Dent Assoc Date: 2022-03-05 Impact factor: 3.454